Tianan Pharmaceutical Financials
| TNPH Stock | USD 0.01 0.00 0.00% |
Tianan |
Understanding current and past Tianan Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Tianan Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Tianan Pharmaceutical's assets may result in an increase in income on the income statement.
Tianan Pharmaceutical Stock Summary
Tianan Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. The company was founded in 2003 and is based in Xian, China. TianAn Pharm is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | US88631V1035 |
| Business Address | International Trade Centre, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.xatazy.com |
| Phone | 86 29 8538 1587 |
| Currency | USD - US Dollar |
Tianan Pharmaceutical Key Financial Ratios
Tianan Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Tianan Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Tianan Pharmaceutical over time and compare it to other companies across industries.Tianan Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Tianan Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Tianan Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Tianan Pharmaceutical competition to find correlations between indicators driving Tianan Pharmaceutical's intrinsic value. More Info.Tianan Pharmaceutical Co is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.72 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Tianan Pharmaceutical Co is roughly 1.39 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Tianan Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Tianan Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Tianan Pharmaceutical Systematic Risk
Tianan Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Tianan Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Tianan Pharmaceutical correlated with the market. If Beta is less than 0 Tianan Pharmaceutical generally moves in the opposite direction as compared to the market. If Tianan Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Tianan Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Tianan Pharmaceutical is generally in the same direction as the market. If Beta > 1 Tianan Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Tianan Pharmaceutical November 24, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Tianan Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Tianan Pharmaceutical Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Tianan Pharmaceutical Co based on widely used predictive technical indicators. In general, we focus on analyzing Tianan Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Tianan Pharmaceutical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.69) | |||
| Maximum Drawdown | 1.89 |
Complementary Tools for Tianan Pink Sheet analysis
When running Tianan Pharmaceutical's price analysis, check to measure Tianan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tianan Pharmaceutical is operating at the current time. Most of Tianan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Tianan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tianan Pharmaceutical's price. Additionally, you may evaluate how the addition of Tianan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |